Skip to main content

Advertisement

SpringerLink
Log in

Introducing combined measles, mumps and rubella vaccine in Chandigarh, India: Issues and concerns!

  • Perspective
  • Published:
Indian Pediatrics Aims and scope Submit manuscript

Abstract

Cyclical outbreaks of mumps have been noticed across Chandigarh city during winter months. Chandigarh does not provide measles, mumps and rubella (MMR) vaccination in the State immunization schedule. Epidemiological shift in age at diagnosis of mumps was noticed with higher incidence in older children and adults. Increased occurrence of complications can be predicted with this age shift. Silent burden of rubella with serious outcomes in newborns further strengthen the case for MMR vaccine inclusion in routine immunization program of Chandigarh.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Gans H, Yasukawa L, Rinki M, De Howitz R, Forghani B, Beeler J. Immune responses to measles and mumps vaccination of infants at 6, 9 and 12 Months. J Infect Dis. 2001;184:817–826.

    Article  CAS  PubMed  Google Scholar 

  2. Galazka AM, Robertson AE, Kraigher A. Mumps and mumps vaccine, a global review. Bull World Health Organ. 1999;77:3–14.

    CAS  PubMed Central  PubMed  Google Scholar 

  3. Peltola H, Heinonen O, Valle M, Paunio M, Virtanen M, Karanko V, et al. The elimination of indigenous measles, mumps and rubella from Finland by a 12 year two dose vaccination program. N Engl J Med. 1994;331:1397–1402.

    Article  CAS  PubMed  Google Scholar 

  4. WHO global status of mumps immunization and surveillance. Weekly Epidemiol Rec. 2005;80:417–424.

  5. Measles, Mumps, and Rubella — Vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1998;47:1–57.

  6. Yadav S, Gupta S, Kumari S. Seroprevalence of rubella in women of reproductive age. Indian J Pathol Microbiol. 1995;38:139–142.

    CAS  PubMed  Google Scholar 

  7. Dewan P, Gupta P. Burden of congenital rubella syndrome (CRS) in India: A systematic review. Indian Pediatr. 2012;49:373–399.

    Article  Google Scholar 

  8. Vijayalakshmi P, Rajasundari TA, Prasad NM, Prakash SK, Narendran K, Ravindran M, et al. Prevalence of eye signs in congenital rubella syndrome in South India: A role for population screening. Br J Ophthalmol. 2007;91:1467–1470.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Chakravarti A, Jain M. Rubella prevalence and its transmission in children. Indian J Pathol Microbiol. 2006;49:54–56.

    PubMed  Google Scholar 

  10. Rajasundari TA, Sundaresan P, Vijayalakshmi P, Brown DW, Jin L. Laboratory confirmation of congenital rubella syndrome in infants: An eye hospital based investigation. J Med Virol. 2008;80:536–546.

    Article  PubMed  Google Scholar 

  11. Galazka AM, Robertson AE, Kraigher A. Mumps and mumps vaccine, a global review. Bull World Health Organ. 1999;77:3–14.

    CAS  PubMed Central  PubMed  Google Scholar 

  12. Technical Advisory Group on Vaccine Preventable Diseases. Vaccination: A Shared Responsibility. Available from: www.paho.org/hq./index.phpoption=com_docman&task=doc. Accessed March 8, 2013.

  13. Singhal T, Amdekar YK, Agarwal RK, editors. IAP Guidebook on Immunisation, IAP Committee on Immunization 2007–2008. New Delhi: Jaypee Brothers Medical Publishers; 2009. P. 16–98.

    Google Scholar 

  14. Singh S, Indian Academy of Paediatrics Committee on Immunization. Update on Immunization Policies, Guidelines and Recommendations. Indian Pediatr. 2004,41;240-2.

  15. World Health Organization. Global status of mumps immunization and surveillance. Wkly Epidemiol Rec. 2005;80:418–424.

    Google Scholar 

  16. Ministry of Health and Family Welfare. Measles Catch-up Immunization Campaign, Guidelines for Planning and Implementation. New Delhi: Government of India 2010. Available from: http://www.unicef.org/india/Operational_guideline_for_Measles_catch_up_immunization_campaign__MoHFW_GoI_(English).pdf. Accessed February 17, 2014.

    Google Scholar 

  17. Sharma KD, Rana KM. MR/MMR vaccine in measles control: A case of missed ppportunity? Indian J Comm Med. 2014;39:49–50.

    Article  Google Scholar 

  18. Status Report on Progress towards Measles and Rubella Climination. SAGE Working Group on Measles and Rubella. Available From: http://www.who.int/immunization/sage/meetings/2013/november/Status_Report_Measles_Rubella21Oct2013_FINAL.pdf. Accessed March 10, 2014.

  19. Taneja D, Sharma P. Targeting rubella for elimination. Indian J Public Health. 2012;56:269–272.

    Article  PubMed  Google Scholar 

  20. Gomber S, Arora SK, Das S, Ramachandran VG. Immune response to second dose of MMR vaccine in Indian children. Indian J Med Res. 2011;134:302–306.

    CAS  PubMed Central  PubMed  Google Scholar 

  21. Universal Immunization Program, National Health Mission. Chandigarh Administration. Available From: http://nrhmchd.gov.in/uip.htm. Accessed January 16, 2014.

  22. Mishra B, Pujharo SK, Dhiman V, Mahalaxmi P, Bharadwaj P, Pokhrel S, et al. Genotyping and subtyping of mumps virus isolates from the Indian subcontinent. Arch Virol. 2013;158:2359–2363.

    Article  CAS  PubMed  Google Scholar 

  23. Deer B. Secrets of the MMR scare. How the case against the MMR vaccine was fixed? BMJ. 2011;342:c5347.

    Article  PubMed  Google Scholar 

  24. World Health Organization. Global Advisory Committee on Vaccine Safety, 16–17 December 2002. Wkly Epidemiol Record. 2003;78:17–20.

    Google Scholar 

  25. Available From: http://indiatoday.intoday.in/story/chandigarh-residents-per-capita-income/1/186614.html Accessed November 17, 2012.

  26. Hinman AR, Zhou E, Reef S. An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States. J Infect Dis. 2004;189: S131–145.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Public Health, PGIMER, Sector 12, Chandigarh, 600 012, India

    Nidhi Bhatnagar, Ravneet Kaur, Madhu Gupta & Deepak Sharma

Authors
  1. Nidhi Bhatnagar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ravneet Kaur
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Madhu Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Deepak Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nidhi Bhatnagar.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bhatnagar, N., Kaur, R., Gupta, M. et al. Introducing combined measles, mumps and rubella vaccine in Chandigarh, India: Issues and concerns!. Indian Pediatr 51, 441–443 (2014). https://doi.org/10.1007/s13312-014-0428-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13312-014-0428-6

Keywords

Search

Navigation